Tri-Institutional TRAC Developmental Core

发展核心：发展核心的目标与整体三机构的目标相同。 结核病研究促进中心（Tri-I TRAC）：1）增加NIH资助的研究人员数量 开展结核病的基础、临床和转化研究; 2）促进多学科结核病研究， 重点关注NIAID结核病科学的五个优先事项。为此，发展核心将征求、审查和资助 为期一年的50，000美元发展项目奖，将帮助NIs和N2 TB研究人员产生 通过协调对基础科学的访问，为未来的R 01或其他资助申请提供初步数据， 临床核心，沿着结构化的指导和专业网络。这些活动将共同 为国家机构创建一个独立培训途径。它每年将提供6个奖项，其中两个将是 每年由威尔康奈尔大学机构基金支持，以促进多样性。除了这个主要角色之外， 发展科学核心还将通过以下方式加强结核病研究中的国家研究机构管道： 本科生和研究生到外地;有助于提高研究生的竞争地位 鼓励医生博士后研究员进入结核病领域 research.因此，发展科学核心将使新的研究人员的可持续管道， 合作转化研究的重点是结核病科学的五个NIAID优先事项， 在全球范围内终结结核病的发病率和死亡率。

The Developmental Core: The goals of the Developmental Core are the same as the overall Tri-Institutional TB Research Advancement Center (Tri-I TRAC): 1) To increase the number of NIH funded investigators conducting basic, clinical and translational research in TB and 2) To foster multidisciplinary TB research with a focus on NIAID’s five priorities for TB science. To do so, the Developmental Core will solicit, review and fund one year Developmental Project Awards of $50,000 that will help NIs and N2TB investigators generate preliminary data for future R01s or other grant applications by coordinating access to the Basic Science and Clinical Cores, along with structured mentorship and professional networking. Together, these activities will create a Training to Independence Pathway for NIs. It will provide 6 awards per year, two of which will be supported annually by Weill Cornell institutional funds to promote diversity. In addition to this primary role, the Developmental Science Core will also bolster the pipeline of NIs in TB research by: introducing undergraduates and graduate students to the field; helping to increase the competitive standing of graduate students for postdoctoral fellowships in the field; and encouraging physician post-doctoral fellows to enter TB research. The Developmental Science Core will thus enable a sustainable pipeline of new investigators and collaborative translational research focused on the five NIAID priorities in TB science and ultimate goal of ending morbidity and mortality from TB worldwide.